Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

The Effect of Low-Dose Proteasome Inhibition on Pre-Existing Atherosclerosis in LDL Receptor-Deficient Mice

Title: The Effect of Low-Dose Proteasome Inhibition on Pre-Existing Atherosclerosis in LDL Receptor-Deficient Mice
Authors: Nicola Wilck; Mandy Fechner; Cristian Dan; Verena Stangl; Karl Stangl; Antje Ludwig
Source: International Journal of Molecular Sciences, Vol 18, Iss 4, p 781 (2017)
Publisher Information: MDPI AG
Publication Year: 2017
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: atherosclerosis; proteasome inhibition; inflammation; Biology (General); QH301-705.5; Chemistry; QD1-999
Description: Dysfunction of the ubiquitin-proteasome system (UPS) has been implicated in atherosclerosis development. However, the nature of UPS dysfunction has been proposed to be specific to certain stages of atherosclerosis development, which has implications for proteasome inhibition as a potential treatment option. Recently, low-dose proteasome inhibition with bortezomib has been shown to attenuate early atherosclerosis in low-density lipoprotein receptor-deficient (LDLR−/−) mice. The present study investigates the effect of low-dose proteasome inhibition with bortezomib on pre-existing advanced atherosclerosis in LDLR−/− mice. We found that bortezomib treatment of LDLR−/− mice with pre-existing atherosclerosis does not alter lesion burden. Additionally, macrophage infiltration of aortic root plaques, total plasma cholesterol levels, and pro-inflammatory serum markers were not influenced by bortezomib. However, plaques of bortezomib-treated mice exhibited larger necrotic core areas and a significant thinning of the fibrous cap, indicating a more unstable plaque phenotype. Taking recent studies on favorable effects of proteasome inhibition in early atherogenesis into consideration, our data support the hypothesis of stage-dependent effects of proteasome inhibition in atherosclerosis.
Document Type: article in journal/newspaper
Language: English
Relation: http://www.mdpi.com/1422-0067/18/4/781; https://doaj.org/toc/1422-0067; https://doaj.org/article/39d21389e96d40789b6399dbf42f5cc3
DOI: 10.3390/ijms18040781
Availability: https://doi.org/10.3390/ijms18040781; https://doaj.org/article/39d21389e96d40789b6399dbf42f5cc3
Accession Number: edsbas.63AA2BF0
Database: BASE